Mevalonate-Ras homology (Rho)/Rho-associated coiled-coil-forming protein kinase (ROCK)-mediated signaling pathway as a therapeutic target for the treatment of endometriosis-associated fibrosis

Current Signal Transduction Therapy

Volumn 5, Issue 2, 2010, Pages 141-148

  Nasu, Kaei ^a   Tsuno, Akitoshi ^a   Yuge, Akitoshi ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Endometriosis; Fibrosis; Mevalonate pathway; Ras homology (Rho); Rho associated coiled coil forming protein kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; RAS PROTEIN; RHO ASSOCIATED COILED COIL FOMING PROTEIN KINASE; RHO FACTOR; RHO KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CYTOSKELETON; DECIDUALIZATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROSIS; GENE SEQUENCE; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; HYPERLIPIDEMIA; MUSCLE CONTRACTILITY; MYOFIBROBLAST; PATHOGENESIS; POLYMERIZATION; PRENYLATION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 77953336841     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436210791112154     Document Type: Article

References (101)

1. Olive DL, Schwartz LB. Endometriosis. New Engl J Med 1993; 328: 1759-69.
2. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997; 68: 585-96.
3. Bonte H, Chapron C, Vieira M, et al. Histologic appearance of endometriosis infiltrating uterosacral ligaments in women with painful symptoms. J Am Assoc Gynecol Laparosc 2002; 9: 519-24.
4. Itoga T, Matsumoto T, Takeuchi H, et al. Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis. Pathol Int 2003; 53: 371-5.
5. Zeitoun K, Takayama K, Sasano H, et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998; 83: 4474-80.
6. Nishida M, Nasu K, Fukuda J, Kawano Y, Narahara H, Miyakawa I. Down-regulation of interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis. J Clin Endocrinol Metab 2004; 89: 5094-100.
7. Browne H, Taylor H. HOXA10 expression in ectopic endometrial tissue. Fertil Steril 2006; 85: 1386-90.
8. Noble L, Simpson E, Johns A, Bulun S. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996; 81: 174-9.
9. Tseng JF, Ryan IP, Milam TD, et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996; 81: 1118-22.
10. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-γ-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod 2005; 11: 29-34.
11. Guan Y-M, Carlberg M, Bruse C, Bergqvist A. Impact of epidermal growth factor and transforming growth factor Beta-1 on the release of fibrinolytic factors from cultured endometrial and ovarian endometriotic stromal cells. Gynecol Obstet Invest 2003; 55: 7-13.
12. Matsuzaki S, Canis M, Darcha C, Dechelotte P, Pouly J-L, Bruhat MA. Fibrogenesis in peritoneal endometriosis. Gynecol Obstet Invest 1998; 47: 197-9.
13. Stovall DW, Anners JA, Halme J. Immunohistochemical detection of type I, III, and IV collagen in endometriotic implants. Fertil Steril 1992; 57: 984-9.
14. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63: 21-9.
15. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as markers of phenotypic modulation. Lab Invest 1990; 63: 144-61.
16. Grinnell F. Fibroblast-collagen-matrix contraction: growth factor signaling and mechanical loading. Trends Cell Biol 2000; 10: 362-5.
17. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001; 12: 2730-41.
18. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-63.
19. Hinz B, Gabbiani G. Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotech 2003; 14: 538-46.
20. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994; 124: 401-4.
21. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996; 76: 69-125.
22. Anaf V, Simon P, Fayt I, Noel J-C. Smooth muscles are frequent components of endometriotic lesions. Hum Reprod 2000; 15: 767-71.
23. Bell E, Sher S, Hull B, et al. The reconstruction of living skin. J Invest Dermatol 1983; 81: 2s-10s.
24. Huang S, Ingber DE. The structural and mechanical complexity of cell-growth control. Nat Cell Biol 1999; 1: E131-8.
25. Jenkins G, Redwood KL, Meadows L, GGreen MR. Effect of gel re-organization and tensional forces on αβ1 integrin levels in dermal fibroblasts. Eur J Biochem 1999; 263: 93-103.
26. Kessler D, Dethlefsen S, Haase I, et al. Fibroblasts in mechanically stressed collagen lattices assume a synthetic phenotype. J Biol Chem 2001; 276: 36575-85.
27. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002; 14: 633-9.
28. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003; 13: 264-9.
29. Goldsmith EC, Hoffman A, Morales MO, et al. Organization of fibroblasts in the heart. Dev Dyn 2004; 230: 787-94.
30. Langevin HM, Bouffard NA, Badger GJ, Iatridis JC, Howe AK. Dynamic fibroblast cytoskeletal response to subcutaneous tissue stretch ex vivo and in vivo. Am J Physiol Cell Physiol 2005; 288: C747-56.
31. Nusgens B, Merrill C, Lapiere C, Bell E. Collagen biosynthesis by cells in a tissue equivalent matrix in vitro. Collagen Relat Res 1984; 4: 351-64.
32. Mauch C, Adelmann-Grill B, Hatamochi A, Krieg T. Collagenase gene expression in fibroblasts is regulated by a three-dimentional contract with collagen. FEBS Lett 1989; 250: 301-5.
33. Bellows CG, Melcher AH, Aubin JE. Contraction and organization of collagen gels by cells cultured from periodontal differences between cell types. J Cell Sci 1981; 50: 299-314.
34. Mochitate K, Pawelek P, Grinnell F. Stress relaxation of contracted collagen gels: disruption of actin filament bundles, release of cell surface fibronectin, and down regulation of DNA and protein synthesis. Exp Cell Res 1991; 193: 198-207.
35. Tomasek JJ, Haaksma CJ, Eddy RJ, Vaughen ME. Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat Res 1992; 232: 359-68.
36. Delvoye P, Wiliquet P, Leveque J-L, Nusgens BV, Lapiere CM. Measurement of mechanical forces generated by skin fibroblasts embedded in the three-dimensional collagen gel. J Invest Dermatol 1991; 97: 898-902.
37. Kolodney MS, Wysolmerski RB. Isometric contraction by fibro-blasts and endothelial cells in tissue culture: a quantitative study. J Cell Biol 1992; 117: 73-82.
38. Eastwood M, McGrouther DA, Brown RA. Fibroblast responses to mechanical forces. Proc Inst Mech Eng 1998; 212: 85-92.
39. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001; 146: 56-66.
40. 2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 2002; 157: 657-63.
41. Ehrlich HP, Rajaratnam JB. Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell 1990; 22: 407-17.
42. Finesmith TH, Broadley KN, Davidson JM. Fibroblasts from wounds different stages of repair vary in their ability to contract a collagen gel in response to growth factors. J Cell Physiol 1990; 144: 99-107.
43. Germain L, Jean A, Auger FA, Garrel DR. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res 1994; 57: 268-73.
44. Garner WL, Rittenberg T, Ehrlich HP, et al. Hypertrophic scar fibroblasts accelerate collagen gel contraction. Wound Rep Regen 1995; 3: 185-91.
45. Tsai C, Hata K, Torii S, Matsuyama M, Ueda M. Contraction potency of hypertrophic scar-derived fibroblasts in a connective tissue model: in vitro analysis of wound contraction. Ann Plast Surg 1995; 35: 638-46.
46. Yuge A, Nasu K, Matsumoto H, Nishida M, Narahara H. Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis. Hum Reprod 2007; 22: 938-44.
47. Gullberg D, Tingstrom A, Thuresson AC, et al. β1-integrinmediated collagen gel contraction is stimulated by PDGF. Exp Cell Res 1990; 186: 264-72.
48. Schiro JA, Chan BM, Roswit WT, et al. Integrin α2β1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell 1991; 67: 403-10.
49. 2+. Mol Biol Cell 1997; 8: 59-71.
50. Ehrlich HP, Rockwell WB, Cornwell TL, Rajaratnam JBM. Demonstration of a direct role for myosin light chain kinase in fibroblast-populated collagen lattice contraction. J Cell Physiol 1991; 146: 1-7.
51. Kolodney MS, Elson EL. Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 1993; 268: 23850-5.
52. Guidry C, Grinnell F. Studies on the mechanism of hydrated collagen gel reorganization by human skin fibroblasts. J Cell Sci 1985; 79: 67-81.
53. Katoh K, Kano Y, Amano M, Onishi H, Kaibuchi K, Fujiwara K. Rho-kinase-mediated contraction of isolated stress fibers. J Cell Biol 2001; 153: 569-84.
54. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70: 389-99.
55. Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997; 11: 2295-322.
56. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509-14.
57. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996; 39: 189-93.
58. Amano M, Mukai H, Ono Y, et al. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science 1996; 271: 648-50.
59. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245-8.
60. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420: 629-35.
61. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 2001; 276: 341-7.
62. Park HJ, Galper JB. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc Natl Acad Sci USA 1999; 96: 11525-30.
63. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990-4.
64. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000; 57: 976-83.
65. 1 in-tegrin receptors. J Cell Sci 1993; 105: 167-77.
66. Ravanti L, Heino J, Lopez-Otin C, Kahari VM. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1999; 274: 2446-55.
67. Rosenfeldt H, Grinnell F. Fibroblast quiescence and the disruption of ERK signaling in mechanically unloaded collagen matrices. J Biol Chem 2000; 275: 3088-92.
68. Grundstrom G, Mosher DF, Sakai T, Rubin K. Integrin αvβ3 m-diates platelet-derived growth factor-BB-stimulated collagen gel contraction in cells expressing signaling deficient integrin (2β1. Exp Cell Res 2003; 291: 463-73.
69. Fringer J, Grinnell F. Fibroblast quiescence in floating or released collagen matrices. J Biol Chem 2001; 276: 31047-52.
70. Carnevali S, Mio T, Adachi Y, et al. Gamma radiation inhibits fibroblast-mediated collagen gel retraction. Tissue Cell 2003; 35: 459-69.
71. Galois L, Hutasse S, Cortial D, et al. Bovine chondrocytes behaviour in three-dimensional type I collagen gel in terms of gel contraction, proliferation and gene expression. Biomaterials 2006; 27: 79-90.
72. Nasu K, Yuge A, Tsuno A, Matsumoto H, Narahara H. Ras homology (Rho)/Rho-associated coiled-coil-forming protein kinase (ROCK)-mediated signaling pathway in endometriosis-associated fibrosis. Res Adv Hum Reprod 2008; 1: 1-9.
73. Molgaard J, Von Schenck H, Olsson AG. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Eur Heart J 1988; 9: 541-51.
74. Hamelin BA, Turgeon J. Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol 1998; 19: 26-37.
75. Davidson M, McKenney J, Stein E, et al. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I. Am J Cardiol 1997; 79: 1475-81.
76. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-30.
77. Graaf MR, Richel DJ, Van Noorden CJ, Guchelaar HJ. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev 2004; 30: 609-41.
78. Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem 1996; 271: 5289-92.
79. Van Aelst L, D'Ssouza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997; 11: 2295-322.
80. Auer J, Berent R, Weber T, Eber B. Clinical significance of pleiotropic effects of statins: lipid reduction and beyond. Curr Med Chem 2002; 9: 1831-50.
81. Menge T, Hartung HP, Stuve O. Statins - a cure-all for the brain? Nat Rev Neurosci 2005; 6: 325-31.
82. Nasu K, Yuge A, Tsuno A, Narahara H. Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril 2009; 92: 2097-9.
83. Aktories K, Braun U, Rösener S, Just I, Hall A. The rho gene prod-uct expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem Biophys Res Comm 1989; 158: 209-13.
84. Aktories K, Weller U, Chhatwal GS. Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. FEBS Lett 1987; 212: 109-13.
85. Rubin EJ, Gill DM, Boquet P, Popoff MR. Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol 1988; 8: 418-26.
86. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509-14.
87. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998; 273: 24266-71.
88. Mraiche F, Cena J, Das D, Vollrath B. Effects of statins on vascular function of endothelin-1. Br J Pharmacol 2005; 144: 715-26.
89. Takeda N, Kondo M, Ito S, Shimokata K, Kume H. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simbastatin. Am J Respir Cell Mol Biol 2006; 35: 722-9.
90. Carlin CM, Peacock AJ, Welssh DJ. Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 2007; 37: 447-56.
91. Lee M-H, Cho YS, Han Y-M. Simbastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Stem Cells 2007; 25: 1654-63.
92. Ruperez M, Rodrigues-Diez R, Blanco-Colio LM, et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis. Role of RhoA/ROCK and MAPK pathways. Hypertension 2007; 50: 377-83.
93. Hirsh J, Raschke R, Warrkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995; 108: 258-75.
94. Becker RC. Optimizing heparin compounds: a working construct for future antithrombotic drug development. J Thromb Thrombolysis 2004; 18: 55-8.
95. Guidry C, Grinnell F. Heparin modulates the organization of hydrated collagen gels and inhibits gel contraction by fibroblasts. J Cell Biol 1987; 104: 1097-103.
96. Schaefer T, Roux M, Stuhlsatz HW, et al. Glycosaminoglycans modulate cell-matrix interactions of human fibroblasts and endothelial cells in vitro. J Cell Sci 1996; 109: 479-88.
97. Nasu K, Tsuno A, Hirao M, Kobayashi H, Yuge A, Narahara H. Heparin is a promising agent for the treatment of endometriosis-associated fibrosis. Fertil Steril [Epub ahead of print]
98. Petraglia F, Tabanelli S, Galassi MC, et al. Human deciduas and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotrophin-releasing factor (CRF) and CRF messenger ribonucleic acid. J Clin Endocrinol Metab 1992; 74: 1427-31.
99. Tabanelli S, Tang B, Gurpide E. In vitro decidualization of human endometrial stromal cells. J Steroid Biochem Mol Biol 1992; 42: 337-44.
100. Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 2007; 25: 445-53.
101. Tsuno A, Nasu K, Yuge A, Matsumoto H, Nishida M, Narahara H. Decidualization attenuates the contractility of eutopic and ectopic endometrial stromal cells: implications for hormone therapy of endometriosis. J Clin Endocrinol Metab 2009; 94: 2516-23.